Company: PMVC
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001213900-25-043278
Chunk: 108

Company: PMV Consumer Acquisition Corp.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 8
Chunk 108
---
holder vote, potentially in a manner that you do not
support, including amendments to our certificate of incorporation.

Further, holders of our Founder Shares will be
entitled to ten (10) votes for each Founder Share held at any annual or special meeting of stockholders or in the case of any written
consent of stockholders in lieu of a meeting and for all purposes. Holders of our public shares will be entitled to one vote for each
such share. Additionally, only holders of our Founder Shares will have the right to vote on the election of directors. Holders of our
public shares will not be entitled to vote on the election of directors.

We may amend the terms of the warrants in
a manner that may be adverse to holders of public warrants with the approval by the holders of at least 50% of the then outstanding public
warrants. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of
shares of our Class A common stock purchasable upon exercise of a warrant could be decreased, all without your approval.

Our warrants were issued in registered form under
a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that
the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but
requires the approval by the holders of at least 50% of the then outstanding public warrants to make any change that adversely affects
the interests of the registered holders of public warrants. Accordingly, we may amend the terms of the public warrants in a manner adverse
to a holder if holders of at least 50% of the then outstanding public warrants approve of such amendment (which would include any public
warrants purchased by our Sponsor or any of our officers or directors).

Although our ability to amend the terms of the
public warrants with the consent of at least 50% of the then outstanding public warrants is unlimited, examples of such amendments could
be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash, shorten the exercise
period or decrease the number of shares of Class A common stock purchasable upon exercise of a warrant.

27

We are an emerging growth company within
the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements available to emerging growth
companies, this could make our securities less attractive to investors and may make it more difficult to